关键词: HRAS mutation epithelial‐myoepithelial carcinoma salivary gland carcinoma

来  源:   DOI:10.1002/ccr3.8099   PDF(Pubmed)

Abstract:
HRAS mutations are frequent genetic alterations in epithelial-myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.
摘要:
HRAS突变是上皮-肌上皮癌中常见的遗传改变,它们可能是有用的辅助分子测试和预测分子测试的靶向治疗替比法尼。
公众号